Bahrain vs Hong Kong: The number of people with susceptibility test result for rifampicin
Bahrain
94.12
in 2021
Hong Kong
94.83
in 2021
Bahrain rank
54th
Hong Kong rank
52nd
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Hong Kong
How they compare
Hong Kong currently reports 94.83 against 94.12 in Bahrain, a difference of 0.71.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Hong Kong ahead.
Bahrain ranks 54th and Hong Kong ranks 52nd of 146 countries.
Across the 2 decades both report, Bahrain averaged higher in 1 and Hong Kong in 1.
Head to head by decade
| Decade | Bahrain | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.36 | 96.18 | 1.17 | Bahrain |
| 2020s | 86.48 | 94.72 | 8.23 | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Hong Kong?
- Hong Kong, at 94.83 against 94.12 in Bahrain as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Hong Kong?
- 0.71, with Hong Kong ahead.
- How many years of comparable data are there for Bahrain and Hong Kong?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Hong Kong rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 54th and Hong Kong ranks 52nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.